{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:44:40Z","timestamp":1792165480125,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T00:00:00Z","timestamp":1541808000000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005646","name":"Actelion, AG, Switzerland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011338","name":"AstraZeneca, AG, Switzerland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011338","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aptalis Pharma, Inc"},{"name":"Dr. Falk Pharma, GmbH, Germany"},{"DOI":"10.13039\/100004330","name":"Glaxo Smith Kline, AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007886","name":"Nestl\u00e9 S. A., Switzerland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis, AG, Switzerland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer, AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Adare Pharmaceuticals, Inc"},{"DOI":"10.13039\/100011338","name":"AstraZeneca, AG, Switzerland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011338","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aptalis Pharma, Inc"},{"name":"Dr. Falk Pharma, GmbH, Germany"},{"DOI":"10.13039\/501100001203","name":"Glaxo Smith Kline, AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007886","name":"Nestl\u00e9 S. A., Switzerland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007886","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Receptos, Inc"},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["32473B_160115"],"award-info":[{"award-number":["32473B_160115"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"TIGERS"},{"name":"CEGIR"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy Clinics of North America"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.giec.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T06:20:36Z","timestamp":1510294836000},"page":"35-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Latest Insights on the Relationship Between Symptoms and Biologic Findings in Adults with Eosinophilic Esophagitis"],"prefix":"10.1016","volume":"28","author":[{"given":"Ekaterina","family":"Safroneeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Straumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain M.","family":"Schoepfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.giec.2017.08.001_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ajg.2013.71","article-title":"ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE)","volume":"108","author":"Dellon","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.giec.2017.08.001_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2050640616689525","article-title":"Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults","volume":"5","author":"Lucendo","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.giec.2017.08.001_bib3","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2010.07.048","article-title":"Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis","volume":"139","author":"Straumann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2017.08.001_bib4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cgh.2012.03.018","article-title":"Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis","volume":"10","author":"Alexander","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.giec.2017.08.001_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/gutjnl-2013-304984","article-title":"Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial","volume":"63","author":"Peyrin-Biroulet","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.giec.2017.08.001_bib6","unstructured":"Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. U.S. Food and Drug Administration. Available at: https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm193282.pdf. Accessed September 6, 2017."},{"key":"10.1016\/j.giec.2017.08.001_bib7","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1097\/MIB.0b013e31829b2a37","article-title":"Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy","volume":"19","author":"De Vos","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.giec.2017.08.001_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cgh.2014.06.026","article-title":"Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis","volume":"13","author":"Katzka","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.giec.2017.08.001_bib9","doi-asserted-by":"crossref","first-page":"e42938","DOI":"10.1371\/journal.pone.0042938","article-title":"Novel device to sample the esophageal microbiome: the esophageal string test","volume":"7","author":"Fillon","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.giec.2017.08.001_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.anai.2016.02.011","article-title":"Eosinophil quantitated urine kinetic: a novel assay for assessment of eosinophilic esophagitis","volume":"116","author":"Cunnion","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.giec.2017.08.001_bib11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1053\/j.gastro.2014.08.028","article-title":"Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis","volume":"147","author":"Schoepfer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2017.08.001_bib12","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/apt.13370","article-title":"Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity","volume":"42","author":"Safroneeva","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.giec.2017.08.001_bib13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/s-0042-107340","article-title":"Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis","volume":"48","author":"Chen","year":"2016","journal-title":"Endoscopy"},{"key":"10.1016\/j.giec.2017.08.001_bib14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.gastro.2015.11.004","article-title":"Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis","volume":"150","author":"Safroneeva","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2017.08.001_bib15","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2013.08.015","article-title":"Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner","volume":"145","author":"Schoepfer","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2017.08.001_bib16","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/all.12733","article-title":"Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study","volume":"70","author":"Giriens","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.giec.2017.08.001_bib17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jaci.2011.09.013","article-title":"Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland","volume":"128","author":"Hruz","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.giec.2017.08.001_bib18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/ibd.21719","article-title":"Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease","volume":"18","author":"Vavricka","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.giec.2017.08.001_bib19","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1136\/annrheumdis-2013-204867","article-title":"Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry","volume":"74","author":"S\u00f8rensen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.giec.2017.08.001_bib20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/apt.12413","article-title":"Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis","volume":"38","author":"Dellon","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"Supplement 1","key":"10.1016\/j.giec.2017.08.001_bib21","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of novel recombinant, humanized, anti-interleukin-13 monoclonal antibody (RPC4046) in patients with active eosinophilic esophagitis: results of the heroes study","volume":"2","author":"Hirano","year":"2016","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.giec.2017.08.001_bib22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-2036.2011.04791.x","article-title":"The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life","volume":"34","author":"Taft","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.giec.2017.08.001_bib23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/dote.12391","article-title":"How to measure disease activity in eosinophilic esophagitis","volume":"29","author":"Schoepfer","year":"2016","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.giec.2017.08.001_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dow028","article-title":"Patient-reported outcome measures in dysphagia: a systematic review of instrument development and validation","volume":"30","author":"Patel","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.giec.2017.08.001_bib25","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/S0016-5085(17)30997-6","article-title":"Budesonide orodispersible tablets are highly effective for treatment of active eosinophilic esophagitis: results from a randomized, double-blind, placebo-controlled, pivotal multicenter trial (EOS-1)","volume":"152","author":"Lucendo","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2017.08.001_bib26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.gastro.2016.11.021","article-title":"Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis","volume":"152","author":"Dellon","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2017.08.001_bib27","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.giec.2017.08.001_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.giec.2017.08.001_bib29","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/apt.14061","article-title":"A\u00a0visual analogue scale and a Likert scale are simple and responsive tools for assessing dysphagia in eosinophilic oesophagitis","volume":"45","author":"Reed","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.giec.2017.08.001_bib30","doi-asserted-by":"crossref","first-page":"S854","DOI":"10.1016\/S0016-5085(17)32941-4","article-title":"Clinical features at baseline are not clearly associated with symptomatic placebo response in adolescents and adults with eosinophilic esophagitis during a placebo run-in period of a double-blind, randomized, controlled trial of budesonide oral suspension","volume":"152","author":"Hirano","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2017.08.001_bib31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/gutjnl-2014-308815","article-title":"A\u00a0randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis","volume":"65","author":"Miehlke","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.giec.2017.08.001_bib32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.giec.2017.08.001_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MCG.0000000000000297","article-title":"Impact of diagnostic delay and other risk factors on eosinophilic esophagitis phenotype and esophageal diameter","volume":"50","author":"Lipka","year":"2016","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.giec.2017.08.001_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2017.202","article-title":"Long-term treatment of eosinophilic esophagitis with swallowed topical corticosteroids: development and evaluation of a therapeutic concept","author":"Greuter","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.giec.2017.08.001_bib35","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.clinthera.2014.04.006","article-title":"Overview of classical test theory and item response theory for the quantitative assessment of items in developing patient-reported outcomes measures","volume":"36","author":"Cappelleri","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.giec.2017.08.001_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12931-014-0124-z","article-title":"Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials","volume":"15","author":"Leidy","year":"2014","journal-title":"Respir Res"}],"container-title":["Gastrointestinal Endoscopy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052515717300934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052515717300934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:20:38Z","timestamp":1760944838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052515717300934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1052515717300934"],"URL":"https:\/\/doi.org\/10.1016\/j.giec.2017.08.001","relation":{},"ISSN":["1052-5157"],"issn-type":[{"value":"1052-5157","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latest Insights on the Relationship Between Symptoms and Biologic Findings in Adults with Eosinophilic Esophagitis","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.giec.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}